Web Content Management
PRODUCTS
-
Our goal is to help your business succeed by working with you to streamline the FDA regulatory process. ProPharma’s team of science- based regulatory consultants commands an unparalleled breadth and depth of knowledge pertaining to FDA’s regulatory framework and can work with you to accomplish your business objectives.
-
Our solid forms plant exports 75% of its output, supplying products to 45 markets in 25 different languages.
-
Discover the expanded DSM series, featuring a 60V/18A option, which provides engineers with greater design flexibility. The DSM series is designed for fast, safe integration into new or existing systems.
-
ProPharma has deep expertise across all signal detection and management activities, including validation, prioritization, and assessment using data from a wide range of sources that are relevant for signal detection for the individual product(s). We are also fully trained and experienced in the EudraVigilance Data Analysis System (EVDAS) functionality and can support MAHs to comply with their obligations for signal detection and management. We leverage our robust knowledge to select the most efficient and effective method(s) for each product that is compliant with legislative requirements.
-
Labeling vaccines in vials and other round formats precisely and in high numbers with HERMA labeling machines.
WHITE PAPERS AND CASE STUDIES
-
Agentic AI And How It's Impacting Clinical Trial Research
Since ChatGPT’s launch in 2022, artificial intelligence has transformed industries worldwide—but the next evolution, Agentic AI, promises to be even more profound.
-
Revolutionizing European Football With UWB Micro-Location
See how UWB micro-location technology was utilized by European League Football to address pandemic-era challenges, but quickly transformed into a vital tool for player analytics and safety monitoring.
-
How eSource Reduced Benchmark's Protocol Deviations By Almost 40%
Explore how a leading vaccine site network selected CRIO to help address the challenges with it's use of paper charts in collecting source data.
-
Overcoming Participant Compliance Challenges In A Medical Device Study
Uncover how Catalyst Clinical Research enhanced participant compliance and streamlined scheduling for a TENS device study using the TrialKit platform, with crucial support from CDS.
-
Expert Consulting And MRCT Strategy Rescues Oncology Program
Uncover how this strategic approach yielded significant outcomes, including uncovering missing data through IB review, streamlining dosing timelines, and achieving successful recruitment milestones.
-
A Digital Solution Embeds Quality Into Cellular Therapeutics Production
Discover how Dendreon cut review and release time by nearly 50% while maintaining a 99% right-first-time rate, which boosts collaboration, visibility, and operational efficiency across teams.
-
PFAS Removal System Proven Effective In Removing Both Long And Short Chain PFAS
A new system removed all nine PFAS compounds from a municipality's water to non-detect levels in a single pass. Unlike traditional methods, it addresses both long- and short-chain PFAS while generating minimal waste.
-
Contamination Control Of Particulate And Shuttle Blow-Fill-Seal Compliance
Does shuttle blow-fill-seal truly meet Annex 1’s stricter contamination standards? New particle burden data challenges industry assumptions and reveals what manufacturers need to know.
-
Enabling Simpler, Quieter, And More Precise Wearables Utilizing Disruptive Pump Technology
Disc pumps enable quieter, smaller, and more precise wearable medical devices, improving patient comfort, measurement accuracy, and system reliability for innovative healthcare solutions.
-
Examining A Phase 1 COVID-19 Clinical Trial
Uncover how we were able to efficiently activate the site and enroll 130 participants within six months, demonstrating our expertise in clinical trial management.
-
Enhancing Phase 1 Clinical Trials With Point-Of-Need Safety Assessments
A Mobile Clinical Suite (MCS) proved to be the solution that Syneos Health needed to resolve their Phase 1 study trial challenges with comprehensive eye exams.
-
Laerdal Error-Proofs Medical Kit Assembly With AI-Powered Vision Verifications
Discover how Laerdal Medical implemented an automated kit assembly solution that enhances quality control and supports continuous improvement through real-time monitoring and visual documentation.
NEWS
-
Alvotech Appoints Dr. Balaji V. Prasad As Chief Strategy Officer3/27/2025
Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Dr. Balaji V. Prasad as Chief Strategy Officer.
-
Daxor's Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems5/13/2025
Daxor Corporation (Nasdaq: DXR), Daxor Corporation, the global leader in blood volume measurement technology, announces the expansion of its innovative diagnostic solutions into two additional U.S. healthcare systems, further advancing the standard of care for cardiovascular and critical care patients nationwide.
-
Serve Robotics To Acquire Diligent Robotics, Expanding Physical AI Platform Beyond The Sidewalk1/20/2026
Serve Robotics Inc. (Nasdaq: SERV) (“Serve” or “the Company”), a leading autonomous robotics company, today announced that it has entered into an agreement to acquire Diligent Robotics, Inc. (“Diligent”), a pioneering provider of AI-powered robot assistants for the healthcare industry.
-
SealSQ And Wecan Announce Collaboration To Develop Post-Quantum KYC Solution To Secure Client Data For The Financial Industry10/14/2025
SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company specializing in the development and commercialization of post-quantum semiconductor technology, and Wecan Group SA (“Wecan”), a leading Swiss provider of global compliance backbone for regulated institutions, today announced a strategic collaboration to develop a Post-Quantum KYC (Know Your Customer) solution.
-
Biodesix Recognized As A Thermo Fisher Scientific Center Of Excellence (COE) For NGS Diagnostics8/19/2025
Biodesix, Inc. (Nasdaq: BDSX), a leader in personalized diagnostics, announced that the company is designated as a Thermo Fisher Scientific Center of Excellence (COE) as part of Thermo Fisher’s collaborative initiative to advance NGS-based diagnostics.